Stay updated on Talazoparib & Enzalutamide in DDR Mutated mCSPC Clinical Trial
Sign up to get notified when there's something new on the Talazoparib & Enzalutamide in DDR Mutated mCSPC Clinical Trial page.

Latest updates to the Talazoparib & Enzalutamide in DDR Mutated mCSPC Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.3.3 was added and the HHS Vulnerability Disclosure link was removed from the footer. These are maintenance updates and do not affect trial data or functionality.SummaryDifference0.1%

- Check13 days agoChange DetectedAdded Contacts/Locations and Study Status sections on 2025-12-12 and removed the item dated 2025-10-15.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed from the history, reflecting an administrative update to the record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check35 days agoChange DetectedThe history shows a new revision (v3.3.1) replacing the previous v3.2.0, which appears to be a minor maintenance update that does not alter page content or study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedDeleted the government funding/operating status notice from the page. The notice previously warned about potential delays in updates due to funding, and its removal does not affect trial information.SummaryDifference0.3%

- Check56 days agoChange DetectedThe new screenshot appears to show a visual/layout update to the page header and spacing, while the underlying list of version history entries remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Talazoparib & Enzalutamide in DDR Mutated mCSPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talazoparib & Enzalutamide in DDR Mutated mCSPC Clinical Trial page.